Answer
St John's wort should be avoided during entrectinib treatment because it is listed among CYP3A/P‑gp inducers that should not be co-administered with entrectinib.
Sources for this answer
- Rozlytrek 100 mg & 200 mg hard capsulesRoche Products Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 16Document updated
Sources checked